Edwards Lifesciences Corp. is no longer acquiring structural heart company JenaValve Technology for $945 million after a U.S. District Court granted the Federal Trade Commission’s motion for an ...
Edwards Lifesciences (EW) said it will no longer pursue the acquisition of heart device developer JenaValve Technology after a federal court in Columbia ruled against the MedTech giant in a case ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results